For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (747)
-
June 03, 2025 | Comment Two years in, UPC’s legal identity is pending with Court of Appeal
...So far, there is only one case to demonstrate the UPC’s approach.Last month, Sanofi Biotechnology and...
Sections: Intellectual Property
-
June 03, 2025 | Press Round-Up Europe Antitrust Europe | 3 Jun 2025
... BloombergFrench pharma company Sanofi has offered to buy immunology specialist Blueprint Medicines...
Sections: Antitrust and Mergers and Acquisitions
-
June 02, 2025 | Press Round-Up United States Antitrust United States | 2 Jun 2025
...“sham” trademark lawsuits to keep prices of allergy medicine Claritin artificially high.Bloomberg- Sanofi...
Sections: Antitrust and Mergers and Acquisitions
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
Already a subscriber? Click here to login